Monique Golding, MD
Family Medicine · Chattanooga, TNNPI 1619941119
Payments from drug & device makers
Across 235 payments — averaging $16.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$901
- Abbott$332
- Amarin Pharma, Inc.$263
- Pfizer$229
- Boehringer Ingelheim$212
- Lilly USA, LLC$201
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,815100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 66 | $901 |
| Abbott | 17 | $332 |
| Amarin Pharma, Inc. | 15 | $263 |
| Pfizer | 15 | $229 |
| Boehringer Ingelheim | 13 | $212 |
| Lilly USA, LLC | 14 | $201 |
| Johnson & Johnson | 14 | $192 |
| Novartis | 12 | $172 |
| Astellas Pharma US Inc | 7 | $156 |
| E.r. Squibb & Sons, L.L.C. | 6 | $144 |
| Amgen(2 entities) | 8 | $118 |
| Inspire Medical Systems, Inc. | 3 | $94 |
| AbbVie | 5 | $92 |
| AstraZeneca | 6 | $85 |
| Boston Scientific | 4 | $81 |
| Bayer | 4 | $73 |
| Medtronic | 1 | $61 |
| Mannkind Corporation | 2 | $41 |
| Biohaven Pharmaceuticals, Inc. | 2 | $34 |
| Actelion Pharmaceuticals US, Inc. | 1 | $31 |
| Exact Sciences | 2 | $31 |
| Esperion Therapeutics, Inc. | 2 | $30 |
| Sanofi-aventis U.S. LLC | 2 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Ironwood Pharmaceuticals, Inc | 2 | $24 |
| GSK | 1 | $23 |
| Merck | 2 | $22 |
| VBI Vaccine (delaware) Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Avanos Medical | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Bardy Diagnostics, Inc. | 1 | $8 |
How this compares
$3,815 in reported general payments places this provider in the 75th percentile of 2,087 family medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 63 | $94,894 |
| EliquisApixaban | 77 | $55,964 |
| JardianceEmpagliflozin | 31 | $31,091 |
| FarxigaDapagliflozin Propanediol | 23 | $23,585 |
| MounjaroTirzepatide | 22 | $22,168 |
| TradjentaLinagliptin | 27 | $20,801 |
| XareltoRivaroxaban | 19 | $20,759 |
| Tresiba Flextouch U-100Insulin Degludec | 33 | $17,605 |
| JanuviaSitagliptin Phosphate | 11 | $16,674 |
| Breo ElliptaFluticasone/Vilanterol | 24 | $13,169 |
| Rosuvastatin Calcium | 385 | $5,203 |
| Atorvastatin Calcium | 365 | $4,536 |
| VyvanseLisdexamfetamine Dimesylate | 11 | $4,295 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 31 | $3,852 |
| Pravastatin Sodium | 196 | $3,737 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $901 | $94,89463 claims |
| PfizerEliquis | $229 | $55,96477 claims |
| Boehringer IngelheimJardiance, Tradjenta | $212 | $51,89358 claims |
| AstraZenecaFarxiga | $85 | $23,58523 claims |
| Lilly USA, LLCMounjaro | $201 | $22,16822 claims |
| Johnson & JohnsonXarelto | $192 | $20,75919 claims |
| MerckJanuvia | $22 | $16,67411 claims |
| GSKBreo Ellipta | $23 | $13,16924 claims |
| AbbVieSynthroid | $92 | $2,13029 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Chattanooga
- Natasha BallardChattanooga$5.7M
- Ellen ClelandChattanooga$38K
- Rickey ManningKnoxville$8.1M
- Kymberly MoyerGallatin$5.9M
- Hina BudhwaniNashville$4.7M
- Paul WakefieldKnoxville$4.3M
- Emily HubbsKingsport$2.8M
- Jerry PunchKnoxville$2.1M
- Bridgette FraneyNashville$2M
- Andrew BrockmyreBristol$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.